Relationship between the time interval from antenatal corticosteroid administration until preterm birth and the occurrence of respiratory morbidity

2011 ◽  
Vol 205 (1) ◽  
pp. 49.e1-49.e7 ◽  
Author(s):  
Femke F. Wilms ◽  
Jolande Y. Vis ◽  
Desiree A.P.M. Pattinaja ◽  
Rosanna A. Kuin ◽  
Monique C. Stam ◽  
...  
2015 ◽  
Vol 6 (3) ◽  
pp. 128-132
Author(s):  
Shripad Hebbar ◽  
Lavanya Rai ◽  
Leslie Lewis ◽  
Prashanth Adiga ◽  
Shyamala Guruvare ◽  
...  

ABSTRACT Objectives To assess the relationship of time interval between antenatal corticosteroid administration and delivery with respiratory distress in premature newborns. Settings Tertiary level teaching hospital Population Preterm deliveries between 28 and 34 weeks in the period of April 2011 to January 2013 where the mothers received one course of corticosteroid prophylaxis and fulfilled the selection criteria. Materials and methods Perusal of the hospital records was made to gather antenatal information and the details of delivery and the newborn. The patients were divided based on the number of doses of steroids received into three groups. The patients receiving complete steroid prophylaxis was further divided based on the time interval between steroid administration and delivery into five groups: 0 to 7 days, 8 to 14, 15 to 21, 22 to 28, 29 days and beyond. We looked for association between neonatal respiratory outcomes and steroid-delivery intervals using Statistical Package for the Social Sciences version 16 (SPSS, Chicago, USA). Regression model was used to control for the confounding variables. Results There were 284 women who delivered preterm (up to 34 weeks of gestation) between April 2011 and January 2013 and fulfilled the selection criteria. The babies who received one (48) or no dose of steroids (14) had a higher incidence of respiratory distress than the ones who received a complete dose. This was statistically significant for babies born up to 32 weeks. Among the rest 222 babies who received complete steroid prophylaxis, 138 (62%) of the neonates born were admitted in NICU, respiratory distress was seen in 62 (28%). Eleven (5%) of the babies required intubation and 22 (9%) required surfactant therapy; there were 12 (5%) neonatal deaths. Multivariable logistic regression analysis showed a slightly increased risk of respiratory morbidity with increased interval from administration to delivery (OR–0.87 for 8–14 days, 1.79 for 15–21 days and 0.16 for 22–28 days). Conclusion The risk of respiratory distress in preterm newborns increases beyond 2 weeks interval between antenatal corticosteroid administration and delivery. How to cite this article Guruvare S, Basu B, Rai L, Lewis L, Hebbar S, Adiga P. Relationship of Time Interval between Antenatal Corticosteroid Administrations to Delivery with Respiratory Distress in Preterm Newborns. Int J Infertil Fetal Med 2015;6(3): 128-132.


2021 ◽  
Author(s):  
Yoav Siegler ◽  
Naphtali Justman ◽  
Gal Bachar ◽  
Roy Lauterbach ◽  
Yaniv Zipori ◽  
...  

Abstract Objective We assessed the association between a short Antenatal Corticosteroid Administration-to-Birth Interval and neonatal outcome. Study design: A retrospective study between 2010- 2020. Eligible cases were singleton preterm live-born neonates born between 24 0/7 and 33 6/7 weeks of gestation and were initiated an ACS course of Betamethasone. We divided the first 48 hours following 1st ACS administration to four-time intervals and compared each time interval to those born more than 48 hours following ACS administration. The primary outcome was a composite of adverse neonatal outcome, including neonatal mortality or any major neonatal morbidity. Results A total of 200 women gave birth less than 48 hours from receiving the first betamethasone injection, and 172 women gave birth within 2-7 days (48-168 hours) from ACS administration. Composite adverse neonatal outcome was higher for neonates born less than 12 hours from initial ACS administration compared to neonates born 2-7 days from first betamethasone injection (55.45% vs. 29.07%, OR 3.45 95% CI [2.02-5.89], p.value<0.0001). However, there was no difference in composite adverse neonatal outcomes between neonates born 12-48 hours following ACS administration and those born after 2-7 days. That was also true after adjusting for confounders. Conclusions 12-24 hours following ACS Administration may be sufficient in reducing the same risk of neonatal morbidities as > 48 hours following ACS administration. It may raise the question regarding the utility of the second dose of ACS.


2007 ◽  
Vol 196 (5) ◽  
pp. 457.e1-457.e6 ◽  
Author(s):  
Allison M. Ring ◽  
Jeffery S. Garland ◽  
Brian R. Stafeil ◽  
Margaret H. Carr ◽  
Gail S. Peckman ◽  
...  

Author(s):  
Moti GULERSEN ◽  
Cynthia GYAMFI-BANNERMAN ◽  
Michelle GREENMAN ◽  
Erez LENCHNER ◽  
Burton ROCHELSON ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document